Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 11;107(4_Suppl):152-159.
doi: 10.4269/ajtmh.21-1268. Print 2022 Oct 11.

Malaria Research for Tailored Control and Elimination Strategies in the Greater Mekong Subregion

Affiliations

Malaria Research for Tailored Control and Elimination Strategies in the Greater Mekong Subregion

Jetsumon Sattabongkot et al. Am J Trop Med Hyg. .

Abstract

The malaria landscape in the Greater Mekong Subregion has experienced drastic changes with the ramp-up of the control efforts, revealing formidable challenges that slowed down the progress toward malaria elimination. Problems such as border malaria and cross-border malaria introduction, multidrug resistance in Plasmodium falciparum, the persistence of Plasmodium vivax, the asymptomatic parasite reservoirs, and insecticide resistance in primary vectors require integrated strategies tailored for individual nations in the region. In recognition of these challenges and the need for research, the Southeast Asian International Center of Excellence for Malaria Research has established a network of researchers and stakeholders and conducted basic and translational research to identify existing and emerging problems and develop new countermeasures. The installation of a comprehensive disease and vector surveillance system at sentinel sites in border areas with the implementation of passive/active case detection and cross-sectional surveys allowed timely detection and management of malaria cases, provided updated knowledge for effective vector control measures, and facilitated the efficacy studies of antimalarials. Incorporating sensitive molecular diagnosis to expose the significance of asymptomatic parasite reservoirs for sustaining transmission helped establish the necessary evidence to guide targeted control to eliminate residual transmission. In addition, this program has developed point-of-care diagnostics to monitor the quality of artemisinin combination therapies, delivering the needed information to the drug regulatory authorities to take measures against falsified and substandard antimalarials. To accelerate malaria elimination, this program has actively engaged with stakeholders of all levels, fostered vertical and horizontal collaborations, and enabled the effective dissemination of research findings.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Annual cases of P. falciparum and P. vivax in the six GMS countries during 2011–2020. Data were extracted from the World Malaria Report 2021. This figure appears in color at www.ajtmh.org.
Figure 2.
Figure 2.
Distribution of confirmed malaria cases in the GMS in 2020. Note the number in China’s Yunnan Province indicates imported malaria cases. This figure appears in color at www.ajtmh.org.

References

    1. Delacollette C et al. 2009. Malaria trends and challenges in the Greater Mekong subregion. Southeast Asian J Trop Med Public Health 40: 674–691. - PubMed
    1. Cui L et al. 2012. Malaria in the Greater Mekong subregion: heterogeneity and complexity. Acta Trop 121: 227–239. - PMC - PubMed
    1. World Health Organization. Regional Office for the Western Pacific , 2015. Strategy for malaria elimination in the Greater Mekong Subregion: 2015–2030. WHO Regional Office for the Western Pacific. https://apps.who.int/iris/handle/10665/208203.
    1. White NJ , 2010. Artemisinin resistance–the clock is ticking. Lancet 376: 2051–2052. - PubMed
    1. Weiss DJ et al. 2021. Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis. Lancet Infect Dis 21: 59–69. - PMC - PubMed

Publication types